Green and Hill Industries, Inc Share Price Other OTC
Equities
GHIL
US39260U1060
Pharmaceuticals
Sales 2013 | - | Sales 2014 | 0 0.01 | Capitalization | 103 8.6K |
---|---|---|---|---|---|
Net income 2013 | - 0 | Net income 2014 | - 0 | EV / Sales 2013 * | - |
Net cash position 2013 * | - 0 | Net cash position 2014 * | - 0 | EV / Sales 2014 * | - |
P/E ratio 2013 * |
-
| P/E ratio 2014 * |
-
| Employees | - |
Yield 2013 * |
-
| Yield 2014 * |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Ross Rebagliati
CEO | Chief Executive Officer | - | 17/14/17 |
Patrick Smyth
PSD | President | - | 17/14/17 |
Lorne Green
SEC | Corporate Secretary | - | 12/13/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick Smyth
PSD | President | - | 17/14/17 |
Lorne Green
SEC | Corporate Secretary | - | 12/13/12 |
Ross Rebagliati
CEO | Chief Executive Officer | - | 17/14/17 |
1st Jan change | Capi. | |
---|---|---|
+40.09% | 6.16B | |
-16.34% | 4.46B | |
-7.11% | 3.27B | |
+5.14% | 3.2B | |
-0.18% | 2.6B | |
+47.93% | 1.98B | |
-7.15% | 1.7B | |
+0.67% | 1.66B | |
-8.73% | 1.61B |